Transplantation. Jul 27;66(2) Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients. Minghelli G(1). This agent promotes uric acid excretion via effects on the organic anion transport The AIIA losartan also produces a uricosuric effect in healthy volunteers. Uricosuric medications (drugs) are substances that increase the excretion of uric acid in the urine, thus reducing the concentration of uric acid in blood plasma. In general, this effect is achieved by action on the proximal tubule of the the uricosurics benzbromarone and losartan had no effect, suggesting these drugs act.
|Genre:||Health and Food|
|Published (Last):||10 October 2010|
|PDF File Size:||7.8 Mb|
|ePub File Size:||12.15 Mb|
|Price:||Free* [*Free Regsitration Required]|
Uricosuric action of losartan via the inhibition of urate transporter 1 URAT 1 in hypertensive patients. There were no statistical differences in the baseline values urocosuric Scr 0. As shown in Table 4benzbromarone did not change renal excretion of urate in these two groups.
Uricosuric – Wikipedia
Renal clearance study uricosruic determine Cur and Ccr was performed as described elsewhere. Furthermore, evaluating quality of life and gout attack free intervals would help quantify the relevance of incorporating losartan with xanthine oxidase inhibitors for gout management. Idiopathic renal hypouricemia is an inherited and heterogeneous disorder characterized by impaired tubular urate transport.
The patients then crossed over to receive the alternate therapy. Related articles in Web of Science Google Scholar. A tribute to Scipione Riva-Rocci.
Angiotensin II type 1 receptor blockers: Contributor Information Marissa L. Nat Rev Rheumatol 6: Losartan plus allopurinol significantly decreased serum uric acid from 6. J Cardiovasc Pharmacol The authors declare no conflicts of interest in preparing this article.
Of note, in the losartan group, the uric acid levels decreased with no effect on serum creatinine, while in the candesartan group, there was no change in uric acid levels but there was a slight increase in serum creatinine.
From those, eight studies met criteria [ Rayner et al. A placebo-controlled, forced titration study. These drugs include all diureticspyrazinoatepyrazinamideethambutolniacinand aspirin.
From Wikipedia, the free encyclopedia. Oxford University Press is a department of the University of Oxford. URAT1 is the central mediator in the transport of uric acid from the kidney into the blood.
The lack of effect of URAT1 inhibitors on renal excretion of urate was independent of the renal function of hypouricemic patients. Because changes in renal excretion of urate induced by angiotensin receptor blockers might be influenced by renal adaptation during their administration, we reexamined the acute effects of candesartan before and 2 h after its administration on renal excretion of urate.
Although serum urate levels are also controlled by the production of uric acid in the liver, losartan and its active metabolite E have been reported to exert no inhibitory effects on the xanthine oxidase activity in an in vitro experiment.
Four individuals experienced an acute gouty attack after being switched from losartan back to enalapril therapy. Table 2 shows the losartn of benzbromarone and losartan on the renal excretion of urate in four hypouricemic hypertensive patients harboring URAT1 mutations hypertensive case nos.
Losartan decreased serum uric acid levels from 7. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. Therefore ARBs play a significant role in the treatment of hypertension and as renoprotective agents [ Michel et al. In some persons with loss-of-function mutations of URAT1, the uricosurics benzbromarone and losartan had no effect, suggesting these drugs act on URAT1 in vivo.
Uricosuric effect of losartan in patients with renal transplants.
Retrieved from ” https: Xanthine oxidase inhibition as a potential treatment for aortic stiffness in hypertension. Author information Copyright and License information Disclaimer. Thirty-two untreated hypertensive outpatients 66 years old on average, 24 males attending Tottori University Hospital, Shinsei Hospital, and Nosaka Clinic Yonago, Japan were enrolled for this study.
Several uricosurics are known to act in vitro by blocking the function of a protein encoded by the gene SLC22A12also known as urate transporter 1 or URAT1. First-line urate-lowering agents are xanthine oxidase inhibitors such as allopurinol and febuxostat.
The effect of angiotensin II receptor blockers on hyperuricemia
There are multiple explanations as to why candesartan and irbesartan do not have the same effects as losartan. Losartan plus benzbromarone significantly decreased serum uric acid from 4. Related articles Gout hypertension losartan uric acid valsartan. While the use of nonsteroidal anti-inflammatory drugs NSAIDsoral glucocorticoids and colchicine are recommended for acute gout attacks, urate-lowering therapy is recommended for individuals with chronic gout consisting of multiple gouty attacks per year and other prespecified conditions as indicated by the treatment guidelines [ Khanna et al.
Thus, use of these drugs is contraindicated in persons already with a high urine concentration of uric acid hyperuricosuria.
This study did not conduct a safety analysis [ Takahasi et al. Drugs used for gout M